B
Bernard Pécoul
Researcher at Drugs for Neglected Diseases Initiative
Publications - 33
Citations - 2061
Bernard Pécoul is an academic researcher from Drugs for Neglected Diseases Initiative. The author has contributed to research in topics: Neglected tropical diseases & Public health. The author has an hindex of 17, co-authored 29 publications receiving 1709 citations.
Papers
More filters
Journal ArticleDOI
Essential medicines for universal health coverage
Veronika J. Wirtz,Hans V Hogerzeil,Andy Gray,Maryam Bigdeli,Cornelis de Joncheere,Margaret Ewen,Martha Gyansa-Lutterodt,Sun Jing,Vera Lucia Luiza,Regina M Mbindyo,Helene Möller,Corrina Moucheraud,Bernard Pécoul,Lembit Rägo,Arash Rashidian,Arash Rashidian,Dennis Ross-Degnan,Dennis Ross-Degnan,Peter Stephens,Yot Teerawattananon,Ellen 't Hoen,Anita K. Wagner,Anita K. Wagner,Prashant Yadav,Michael R. Reich +24 more
TL;DR: Author(s): Wirtz, Veronika J; Hogerzeil, Hans V; Gray, Andrew L; de Joncheere, Cornelis P; Ewen, Margaret A; Gyansa-Lutterodt, Martha; Jing, Sun; Luiza, Vera L; Mbindyo, Regina M; Moller, Helene; Moucheraud, Corrina; Pecoul, Bernard; Rago, Lembit; Rashidian, Arash
Journal ArticleDOI
Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
Els Torreele,Bernadette Bourdin Trunz,David Tweats,David Tweats,Marcel Kaiser,Marcel Kaiser,Reto Brun,Reto Brun,Guy Mazué,Michael A. Bray,Bernard Pécoul +10 more
TL;DR: Fexinidazole is shown to be a short-course, safe and effective oral treatment curing both acute and chronic HAT and that could be implemented at the primary health care level and the results of the preclinical pharmacological and safety studies indicate that fexinidrazole is a safe andeffective oral drug candidate with no untoward effects that would preclude evaluation in man.
Journal ArticleDOI
The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment
Belen Pedrique,Nathalie Strub-Wourgaft,Claudette Some,Piero Olliaro,Piero Olliaro,Patrice Trouiller,Nathan Ford,Bernard Pécoul,Jean-Hervé Bradol +8 more
TL;DR: The research and development pipeline of drugs and vaccines for neglected diseases from 2000 to 2011 shows a persistent insufficiency in drug and vaccine development for neglected Diseases, with a slight improvement during the past 12 years.
Journal ArticleDOI
New, improved treatments for Chagas disease: from the R&D pipeline to the patients.
Isabela Ribeiro,Ann-Marie Sevcsik,Fabiana Alves,Graciela Diap,Robert Don,Michael O. Harhay,Shing Chang,Bernard Pécoul +7 more
TL;DR: The appearance of Trypanosoma cruzi in blood banks in the United States has led the Food and Drug Administration (FDA) to recently issue a draft guidance on CD screening.
Journal ArticleDOI
“Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
Peter J. Hotez,Bernard Pécoul +1 more
TL;DR: With a global dialogue now underway, this is an appropriate time to present an eight-point manifesto about how future resources and investments should be best allocated, particularly in terms of an appropriate balance between implementation and R&D.